Brazil and Mexico Lead IVD Investments in Latin America

/0 Comments/by Daniel Granderson
Read more

2023 Healthcare Trend: Growth in $21 Billion Molecular Diagnostics Market

/by Daniel Granderson

Future molecular IVD sales buoyed by COVID-19, infectious diseases, and sexually transmitted infections There is a market in excess of $21 billion for molecular testing technologies, reveals medical market research publisher Kalorama Information in The World Market for Molecular Diagnostics Tests, 11th Edition, a recent report added to the firm’s Knowledge Center subscription.  The majority […]

Read more

127.4 Billion-Dollar IVD Market Blooms

/by Bruce Carlson

Abbott Leads, Roche Close Second. COVID -19 Tests Largest Share, But Growth Comes from non-COVID The world in vitro diagnostic (IVD) market will reach $127.4 billion dollars in 2022, according to LabPulse.com’s sister publication Kalorama Information.  That’s the finding from the firm’s market research report, The Worldwide Market for In Vitro Diagnostics, 15th edition.  REPORT: […]

Read more

Laboratory Industry Doesn’t Forget COVID-19, But Shifts Focus to Other Health Conditions at AACC 2022 in Chicago

/by Daniel Granderson

Urgent healthcare problems were addressed at the 2022 American Association for Clinical Chemistry (AACC) meeting of lab professionals and IVD vendors in Chicago.  Kidney disease, drugs of abuse, hematology and liver disease were among areas of new product development and studies. Medical market research firm Kalorama Information (www.kaloramainformation.com) notes there were 331 contract manufacturers, 42 […]

Read more

The Middle East and Africa Region a $4 Billion Hotbed for IVD Investment

/by Daniel Granderson

Globally, in vitro diagnostic (IVD) companies are exploring opportunities in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care.  As the COVID-19 dust settles, it is expected that the interest in geographic expansion will once again return to the Middle East and […]

Read more

106 Billion IVD Procedures and Counting

/by Daniel Granderson

“Medical market researcher Kalorama Information forecasts exponential growth in both in vitro diagnostics (IVD) procedures and sales between 2021 and 2026.”   The global in vitro diagnostics (IVD) procedures market continues to grow off momentum originating at the height of the pandemic and lingering on today. There are currently 106,624 million (106 billion) in vitro […]

Read more

COVID-19 and 6 Other Trends Impacting the In Vitro Diagnostics (IVD) Market

/by Daniel Granderson

  “In many ways, the IVD testing market is center stage for the fight against the coronavirus…The COVID-19 market continues to play a major role in the growth of the IVD market with tests for the virus representing 27% of sales in 2021.” – Kalorama Information   Make no mistake, the in vitro diagnostics (IVD) […]

Read more

Cancer IVD: 4 Trends to Watch in $5.5 Billion Market

/by Daniel Granderson

  Whether affecting the lungs, colorectal system, stomach, liver, breasts, or other parts of the body, few medical maladies carry the inherent gravitas of cancer. Annually, millions of new cancer cases are diagnosed and millions of cancer linked deaths occur worldwide.  Undoubtedly, cancer poses one of the greatest threats to human health globally. This proliferating […]

Read more

Allergy Immunoassay Market at $612.5 Million with 30%-40% of World Population Affected

/by Daniel Granderson

  Allergy statistics show that allergy conditions, triggered by anything from foods to venoms to vaccines and more, are constantly present in our lives and are not going away. In fact, the rising prevalence of allergies has created a market for allergy immunoassays—including lab-based allergy immunoassays and POC-based allergy immunoassays—that will reach an estimated $612.5 […]

Read more

In Vitro Diagnostic Market Swells To Largest Level Ever, 117 Billion Dollars

/by Daniel Granderson

The in vitro diagnostics market was $25.2 billion dollars in 2001. It now exceeds $117 billion, according to Kalorama Information’s new report on the in vitro diagnostics market. Not only has COVID-19 testing volumes persisted despite the presence of a vaccine, but other test markets have recovered. This has lead to a 12% increase in the market between […]

Read more